X
WST icon

Xponance’s West Pharmaceutical WST Stock Holding History

Xponance’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.55M Buy
12,664
+121
+1% +$37K 0.03% 407
2026
Q1 		$3.14M Buy
12,543
+1,641
+15% +$408K 0.02% 461
2025
Q4 		$3M Buy
10,902
+652
+6% +$178K 0.02% 450
2025
Q3 		$2.69M Sell
10,250
-438
-4% -$106K 0.02% 467
2025
Q2 		$2.34M Sell
10,688
-3,624
-25% -$775K 0.02% 502
2025
Q1 		$3.2M Sell
14,312
-390
-3% -$107K 0.03% 404
2024
Q4 		$4.82M Sell
14,702
-2,056
-12% -$647K 0.04% 313
2024
Q3 		$5.03M Buy
16,758
+2,667
+19% +$817K 0.05% 304
2024
Q2 		$4.64M Sell
14,091
-2,962
-17% -$1.05M 0.05% 301
2024
Q1 		$6.75M Buy
17,053
+483
+3% +$179K 0.07% 231
2023
Q4 		$5.83M Sell
16,570
-829
-5% -$293K 0.07% 230
2023
Q3 		$6.53M Buy
17,399
+297
+2% +$115K 0.09% 189
2023
Q2 		$6.54M Buy
17,102
+204
+1% +$72.9K 0.09% 197
2023
Q1 		$5.85M Sell
16,898
-373
-2% -$109K 0.09% 222
2022
Q4 		$4.06M Buy
17,271
+2,248
+15% +$533K 0.07% 275
2022
Q3 		$3.7M Buy
15,023
+1,049
+8% +$320K 0.07% 253
2022
Q2 		$4.22M Buy
13,974
+1,300
+10% +$423K 0.08% 199
2022
Q1 		$5.21M Sell
12,674
-7,725
-38% -$3.02M 0.09% 191
2021
Q4 		$9.57M Sell
20,399
-7,113
-26% -$3.06M 0.15% 118
2021
Q3 		$11.7M Sell
27,512
-419
-2% -$177K 0.22% 81
2021
Q2 		$10M Buy
27,931
+17,122
+158% +$5.66M 0.18% 97
2021
Q1 		$3.05M Buy
10,809
+2
+0% +$572 0.06% 239
2020
Q4 		$3.06M Buy
10,807
+207
+2% +$58.1K 0.07% 239
2020
Q3 		$2.91M Sell
10,600
-36
-0.3% -$9.53K 0.07% 219
2020
Q2 		$2.42M Buy
+10,636
New +$2.09M 0.06% 237

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Xponance's WST Position: Q2 2026 in Review

Xponance increased its West Pharmaceutical (WST) stake by 0.96% in Q2 2026, buying an estimated $37K and bringing the position to 12,664 shares worth $4.55M. The position accounts for 0.03% of the portfolio, ranked #407.

Xponance first reported a position in WST in Q2 2020 and has held it in 25 quarters since. The position peaked at $11.7M in Q3 2021. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Xponance held 12,664 shares of West Pharmaceutical worth $4.55M as of Q2 2026.
  • Xponance bought 121 West Pharmaceutical shares in Q2 2026, an estimated $37K.
  • West Pharmaceutical made up 0.03% of Xponance's portfolio in Q2 2026, its #407 holding.
  • Xponance first reported a position in West Pharmaceutical in Q2 2020 and has held it in 25 quarters since.
  • Xponance's West Pharmaceutical position peaked at $11.7M in Q3 2021.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.